Pedro Henrique Dias Moura Prazeres

Doutorando no Programa de Pós-Graduação em Patologia do ICB UFMG. Mestre em Patologia pela Universidade Federal de Minas Gerais (2018-2020), quando trabalhou com modelos animais transgênicos no estudo do microambiente tumoral da próstata. Graduado em Farmácia pela UFMG (2017). Foi bolsista de iniciação científica pela FAPEMIG no Departamento de Fisiologia e Biofísica (2013-2015), onde atuou com técnicas de cultivo celular, biologia molecular e citometria de fluxo e pelo CNPq (2016-2017), onde atuou com modelos experimentais de tumor in vivo. Participou do programa Ciências sem Fronteiras (2015-2016) no Limerick Institute of Technology (Irlanda), onde atuou com técnicas de análise instrumental aplicada a pesquisa forense. Atualmente trabalha com o desenvolvimento de imunoterapia com células CAR T utilizando uma plataforma de nanopartículas lipídicas ionizáveis.

PhD student at the Graduate Program in Pathology at ICB UFMG. Master in Pathology from the Federal University of Minas Gerais (2018-2020), when he worked with transgenic animal models in the study of the prostate tumor microenvironment. Graduated in Pharmacy from UFMG (2017). He was a scientific initiation fellow by FAPEMIG in the Department of Physiology and Biophysics (2013-2015), where he worked with cell culture techniques, molecular biology and flow cytometry and by CNPq (2016-2017), where he worked with experimental models of tumor in vivo. He participated in the Science without Borders program (2015-2016) at the Limerick Institute of Technology (Ireland), where he worked with instrumental analysis techniques applied to forensic research. He is currently working on the development of CAR T cell immunotherapy using an ionizable lipid nanoparticle platform.